Company Analysis

ADMA Biologics Inc (ADMA)

Nasdaq: ADMA · Biological Products, (No Diagnostic Substances) · Ramsey, NJ · filing with the SEC since 2006
Grade6.5
◀ Past 6.8● Present 7.8▶ Future 4.7

Who runs ADMA Biologics Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Grossman Adam S
President and CEO. First filing Feb 2012, latest Nov 5, 2026, 27 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
19 people on the record since 2012
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Grossman Adam SPresident and CEOFeb 2012Nov 5, 202610 · $3.2M
Kestenberg-Messina Kaitlin M.COO and SVP, ComplianceMar 2024Jul 28, 20261 · $200,000
Kohler TerryCFO and TreasurerFeb 2026Jul 17, 2026none
Tade Brad L.CFO and TreasurerJul 2024Feb 23, 2026none
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Grossman Jerrold BdirectorFeb 2012May 28, 2026none
Guiheen Lawrence P.directorJul 2012Mar 17, 2026none
Elms StevedirectorFeb 2012Mar 9, 2026none
Finger Alison CecilydirectorOct 2023Feb 11, 2026none
Kwon YoungdirectorOct 2021Feb 11, 2026none
Salas Eduardo RenedirectorJan 2025Feb 11, 2026none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ADMA · research, not advice